News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
Tevard Biosciences Presents Preclinical Data Showing Complete Dystrophin Restoration and Robust Titin Rescue with Suppressor tRNA Therapy at ASGCT 2026
May 14, 2026
·
1 min read
Press Releases
OS Therapies Appoints Industry Leader Dr. Craig Eagle as Chief Medical Advisor
May 14, 2026
·
7 min read
Press Releases
BioHarvest Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026
·
15 min read
Press Releases
BioHarvest Sciences Appoints New Head of Business Development for its CDMO Division
May 14, 2026
·
4 min read
Press Releases
TempraMed Announces Granted Indian Design Patent for VIVI Cap Smart Product
May 14, 2026
·
10 min read
Press Releases
PharmaDrug Sairiyo Therapeutics to Explore PD-001, Its Patented Reformulated Cepharanthine, for Hantavirus
May 13, 2026
·
10 min read
Press Releases
PharmaTher’s Sairiyo Therapeutics to Explore PD-001, Its Patented Reformulated Cepharanthine, for Hantavirus
May 13, 2026
·
9 min read
Press Releases
BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications
May 13, 2026
·
6 min read
Press Releases
Restart Life Sciences Leverages Amazon Logistics for Strategic Entry of Holy Crap Foods into U.S. Market
May 13, 2026
·
4 min read
Press Releases
PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement
May 12, 2026
·
5 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us